CB Lozzio

5.2k total citations · 2 hit papers
10 papers, 4.6k citations indexed

About

CB Lozzio is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, CB Lozzio has authored 10 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Immunology. Recurrent topics in CB Lozzio's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and T-cell and Retrovirus Studies (3 papers). CB Lozzio is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and T-cell and Retrovirus Studies (3 papers). CB Lozzio collaborates with scholars based in United States. CB Lozzio's co-authors include BB Lozzio, DW Golde, B B Lozzio, S Krauß, Carl J. Wust and DW Golde and has published in prestigious journals such as Blood.

In The Last Decade

CB Lozzio

10 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1975 2.5k citations CB Lozzio, BB Lozzio Blood profile →
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1975 2.0k citations CB Lozzio, BB Lozzio Blood profile →

Peers

CB Lozzio

MB

HEMAT

IMMUN

ONCOL

GENET

BB Lozzio United States

R Silber United States

D H Pluznik United States

Motoo Hozumi Japan

Jürgen Mestan Switzerland

Bernard Sordat Switzerland

Shiro Akinaga Japan

Kurt Bommert Germany

Kelvin P. Lee United States

G Laurent France

BB Lozzio United States

CB Lozzio

2.3k ×1.0

MB

1.3k ×1.0

HEMAT

1.2k ×1.0

IMMUN

891 ×1.0

ONCOL

780 ×1.0

GENET

Citations per year, relative to CB Lozzio CB Lozzio (= 1×) peers BB Lozzio

Countries citing papers authored by CB Lozzio

Since Specialization

Citations

This map shows the geographic impact of CB Lozzio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CB Lozzio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CB Lozzio more than expected).

Fields of papers citing papers by CB Lozzio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CB Lozzio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CB Lozzio. The network helps show where CB Lozzio may publish in the future.

Co-authorship network of co-authors of CB Lozzio

This figure shows the co-authorship network connecting the top 25 collaborators of CB Lozzio. A scholar is included among the top collaborators of CB Lozzio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CB Lozzio. CB Lozzio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Lozzio, CB & BB Lozzio. (2011). Human chronic myelogenous leukemia cell-line with positive Philadelphia. 3 indexed citations

2.

Lozzio, CB, et al.. (1984). Proliferation and differentiation of human myeloid leukemic cells in immunodeficient mice: electron microscopy and cytochemistry. Blood. 63(5). 1015–1022. 22 indexed citations

3.

Lozzio, BB, et al.. (1983). Proliferation of human malignant hematopoietic cells in immunodeficient mice: suppression by antibody to pluripotent K-562 leukemia cells involves direct cytolysis and effector cells. Blood. 61(6). 1045–1053. 2 indexed citations

4.

Wust, Carl J., et al.. (1982). Antibody-dependent cytolysis of the human leukemia cell line K-562 in the absence of effector cells or complement. Blood. 59(1). 133–140. 12 indexed citations

5.

Lozzio, CB, et al.. (1981). Human myeloid cell lines [letter]. Blood. 57(5). 979–980. 5 indexed citations

6.

Lozzio, CB, et al.. (1981). Human myeloid cell lines [letter]. Blood. 57(5). 979–980. 3 indexed citations

7.

Lozzio, CB, et al.. (1978). Correlation of leukemia-associated antigens and Ph1 chromosome in fibroblastlike cells derived from bone marrow. Blood. 52(4). 673–680. 5 indexed citations

8.

Lozzio, BB, et al.. (1977). Leukemia-associated antigens detected by a nonhuman primate antiserum to a Ph1+ myeologenous leukemia cell line. Blood. 50(1). 115–124. 17 indexed citations

9.

Lozzio, CB & BB Lozzio. (1975). Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45(3). 321–334. 2523 indexed citations breakdown →

10.

Lozzio, CB & BB Lozzio. (1975). Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45(3). 321–334. 2032 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact